Conference notes 8/13

Myasthenic Crisis

  • anti-AChR auto antibodies
  • ocular bulbar, limb symptoms, weakness worsens with muscle use
  • Many meds can cause exacerbation i.e. macrolides, fluoroquinolones, levophed, laxatives etc.
  • most on pyridostigmine at home
  • infection/pregnancy common precipitants
  • Bedside PFT, basic labs, tsh, hcg, cxr, r.o CVA
  • 20-30-40 rule> FCV below 20, MIP below 30, MEP 40 consider intubation; NIF <30
  • Will need increased dose of succinylcholine about double (depolarizing), less of roccuronium about half
  • Treatment IvIG vs. plasmapharesis

Febrile seizure

  • H and P
    • seizure characteristics
    • duration
    • recorded? video? can they act it out?
    • sick symptoms/contaqcts
    • PMHx, developmental hx IUTD, seizure hx
    • Fever causes that can be treated with ABX
  • Seizure education/precautions
  • Rescue meds> consider nasal vs rectal
  • treat benzo x2> keppra load
  • Consider intubation IF going on a drip

Pharmacology

  • Status epilepticus
  • SE neurocritical care society: 5 minutes or more of continuous clinical or electrical seizure activity or recurrent seizure without return to baseline
  • refractory SE with highest mortality
  • Treatment approach:
    • Consider levels
    • POC labs/EKG/Blood gas/valproate level/carbamazepime/phenytoin levels (all can run in house) keppra is a send out
    • Benzos: diazepam ( IV: 0.15-0.2 mg/kg max 10mg, Rectal: 0.2-0.5 mg/kg max 20mg, rapid onset, long half life, major hepatic clearance), lorazepam ( IV 0.1mg/kg max 4mg, may repeat once, fast onset, moderate half life, limited hepatic clearance) Midazolam ( IV 0.2mg/kg max 10mg can repeat once, IM 5mg, 10mg for >40kg, single dose, IN 5mg one nostril, may repeat once, rapid onset, very lipophilic)
    • IM midazolam non-inferior to IV lorazepam
    • lorazepam> faster seizure cessation
    • Midaz> faster time to administer
    • Sodium channel agonists: prevent further propagation for action potential between neurons, phenytoin ( max 50mg/min, need inline filter, high protein binding, cardio/hepato toxic, extrav (purple glove syndrome) and derm reactions) Fosphenytoin (converted to phenytoin w/in 15 min IV admin, 20mgPE/kg max 1500, infuse max 150mgPE/min no inline filter, decreased cardiotoxicity and extrav problems, still do therapeutic drug monitoring like phenytoin) valproic acid blocks na/ca/ channels, potentiates GABA( 40mg/kg max 3g, hepatotoxic, thrombocytopenia, hyperammonemia, derm reactions, dose dependent) Lacosamide (400mg single IV dose, arrhythmia, diplopia, derm reactions, renally excreted, EKG before administering)
    • Racatems (levetiracetam) Keppra blocks Ca and AMPA receptors, 60mg/kg max 4.5g, psych disturbances
    • Barbs: direct GABA-A agonists, some glutamate antagonism at high doses Phenobarbital (IV 15mg/kg, rapid onset, very long half life up to 120hrs, hepatic clearance avoid in liver pts) Pentobarbital ( 15mg/kg cumulative bolus, maintenance 0.5-5mg/kg/hr, drug monitoring, long half life, cardiac dysfunction,, hypotension, propylene glycol toxicity, severe ileus, hepatotoxicity)
  • Tips: best agent is the one most readily available, consider avoiding phenytoin/phospheny, consider alternative from home reg, consider avoiding valproic acid and pheny/fospheny, avoid valproic acid in pregnancy, remember drug interactions.
  • RSI considerations: ketamine/propofol for induction, succs is preferred d/t quick on and off, rocc not preferred d/t duration bc might suppress seizure activity
  • Myasthenia Gravis
  • RSI considerations: Succinylcholine 2mg/kg 2x normal dose, must overcome antibodies, rocuronium 0.6 mg/kg (about half), preferred for RSI since does not act on receptors.

Stroke prehospital

  • should be dispatched high priority
  • CSTAT- intended to identify LVO, Gaze Arm weakness, LOC
  • Must determine LKN

TBI EMS

  • EPIC study
  • aggressively prevent and treat “three H bombs of TBI” hypoxemia, hypotension, hyperventilation
  • EPIC studies showed increase survival in all groups